Nery R, Barsoum A L, Bullman H, Neville A M
Biochem J. 1974 May;139(2):431-40. doi: 10.1042/bj1390431.
Urines of several patients with urothelial carcinomas contain inhibitors of the immunoreaction between carcinoembryonic antigen derived from human colorectal carcinomas and monospecific goat antiserum raised against the antigen. These inhibitors range in approximate molecular weights from less than 1000 to several millions, and two have been isolated by a combination of extraction, gel filtration and electrophoretic procedures. These are respectively a macromolecular aggregate, component UCEA-3, which is excluded by Sepharose 4B, and a glycoprotein(s) component, UCEA-1, with mean molecular weight (2x10(5)) similar to that of carcinoembryonic antigen. Comparison of the properties of component UCEA-1 and carcinoembryonic antigen on gel filtration, electrophoresis, immunoelectrophoresis and density gradient ultracentrifugation indicates that these substances of similar molecular size and net charge differ in some immunochemical properties.
几位尿路上皮癌患者的尿液中含有一些抑制剂,这些抑制剂能够抑制源自人结肠直肠癌的癌胚抗原与针对该抗原产生的单特异性山羊抗血清之间的免疫反应。这些抑制剂的近似分子量范围从小于1000到数百万,并且通过萃取、凝胶过滤和电泳程序相结合的方法分离出了两种抑制剂。它们分别是一种大分子聚集体,即UCEA - 3成分,它不能通过琼脂糖4B凝胶过滤;还有一种糖蛋白成分,即UCEA - 1,其平均分子量(2×10⁵)与癌胚抗原相似。通过凝胶过滤、电泳、免疫电泳和密度梯度超速离心对UCEA - 1成分和癌胚抗原的特性进行比较表明,这些分子大小和净电荷相似的物质在一些免疫化学特性上存在差异。